Large take-up of RSV jab for babies in Rotunda Hospital on first day of roll-out

Professor Sean Daly expressed optimism regarding the newly introduced nirsevimab, stating that 76 of 80 newborns received the jab on its first day, indicating high acceptance. He praised the dedication of midwives who volunteered to assist.

The jab nirsevimab, administered in a single dose to newborns, offers immediate protection against RSV by providing antibodies directly for 150 days, which is crucial for infant health.

RSV, known to impact infants severely, resulted in over 1,000 hospitalizations last winter in Ireland. The new jab could potentially decrease admissions by 453, showcasing its importance.

While some European nations have already implemented nirsevimab, achieving a 90% immunization rate in Spain, Ireland's uptake could significantly lower hospitalizations, highlighting the jab's potential impact.

Read at Irish Independent